Open Access
Open access
volume 70 pages 103059

A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization

Chunlu Li 1, 2
Chengsi Deng 1, 2
Siwei Wang 1, 2
Si-wei Wang 1, 2
Xiang Da Dong 1, 2
Dan Bing 3
Bing Dai 3
Wendong Guo 1, 2
QIQIANG GUO 1, 2
Qiqiang Guo 1, 2
Yan-Ling Feng 1, 2
Hongde Xu 1, 2
Xiaoyu Song 1, 2
Liu Cao 1, 2
Publication typeJournal Article
Publication date2024-04-01
scimago Q1
wos Q1
SJR3.374
CiteScore19.5
Impact factor11.9
ISSN22132317
Organic Chemistry
Biochemistry
Clinical Biochemistry
Abstract
Reactive oxygen species (ROS) play a pivotal role in macrophage-mediated acute inflammation. However, the precise molecular mechanism by which ROS regulate macrophage polarization remains unclear. Here, we show that ROS function as signaling molecules that regulate M1 macrophage polarization through ataxia-telangiectasia mutated (ATM) and cell cycle checkpoint kinase 2 (Chk2), vital effector kinases in the DNA damage response (DDR) signaling pathway. We further demonstrate that Chk2 phosphorylates PKM2 at the T95 and T195 sites, promoting glycolysis and facilitating macrophage M1 polarization. In addition, Chk2 activation increases the Chk2-dependent expression of p21, inducing cell cycle arrest for subsequent macrophage M1 polarization. Finally, Chk2-deficient mice infected with lipopolysaccharides (LPS) display a significant decrease in lung inflammation and M1 macrophage counts. Taken together, these results suggest that inhibiting the ROS-Chk2 axis can prevent the excessive inflammatory activation of macrophages, and this pathway can be targeted to develop a novel therapy for inflammation-associated diseases and expand our understanding of the pathophysiological functions of DDR in innate immunity.
Found 
Found 

Top-30

Journals

1
2
3
4
5
Advanced Science
5 publications, 7.14%
International Immunopharmacology
3 publications, 4.29%
International Journal of Molecular Sciences
2 publications, 2.86%
Bioactive Materials
2 publications, 2.86%
Discover Oncology
2 publications, 2.86%
Redox Biology
2 publications, 2.86%
International Journal of Biological Macromolecules
2 publications, 2.86%
Chemical Engineering Journal
2 publications, 2.86%
ACS applied materials & interfaces
2 publications, 2.86%
Materials Today Bio
2 publications, 2.86%
Advanced Functional Materials
2 publications, 2.86%
Frontiers in Pharmacology
2 publications, 2.86%
Journal of Inflammation Research
2 publications, 2.86%
Frontiers in Immunology
1 publication, 1.43%
Cellular Signalling
1 publication, 1.43%
Biochimica et Biophysica Acta - Molecular Cell Research
1 publication, 1.43%
Cellular and Molecular Life Sciences
1 publication, 1.43%
Advanced healthcare materials
1 publication, 1.43%
Journal of Advanced Research
1 publication, 1.43%
Journal of Materials Chemistry B
1 publication, 1.43%
Journal of Nanobiotechnology
1 publication, 1.43%
Biochemical and Biophysical Research Communications
1 publication, 1.43%
Biofabrication
1 publication, 1.43%
Advances in Clinical Medicine
1 publication, 1.43%
Cell Death and Differentiation
1 publication, 1.43%
Signal Transduction and Targeted Therapy
1 publication, 1.43%
Journal of Colloid and Interface Science
1 publication, 1.43%
Scientific Reports
1 publication, 1.43%
Biomaterials
1 publication, 1.43%
Colloids and Surfaces B: Biointerfaces
1 publication, 1.43%
1
2
3
4
5

Publishers

5
10
15
20
25
30
Elsevier
28 publications, 40%
Springer Nature
12 publications, 17.14%
Wiley
11 publications, 15.71%
Frontiers Media S.A.
4 publications, 5.71%
American Chemical Society (ACS)
4 publications, 5.71%
MDPI
3 publications, 4.29%
Taylor & Francis
3 publications, 4.29%
Royal Society of Chemistry (RSC)
1 publication, 1.43%
IOP Publishing
1 publication, 1.43%
Hans Publishers
1 publication, 1.43%
Association for Research in Vision and Ophthalmology (ARVO)
1 publication, 1.43%
Baishideng Publishing Group
1 publication, 1.43%
5
10
15
20
25
30
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
70
Share
Cite this
GOST |
Cite this
GOST Copy
Li C. et al. A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization // Redox Biology. 2024. Vol. 70. p. 103059.
GOST all authors (up to 50) Copy
Li C., Deng C., Wang S., Wang S., Dong X. D., Bing D., Dai B., Guo W., GUO Q., Guo Q., Feng Y., Xu H., Song X., Cao L. A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization // Redox Biology. 2024. Vol. 70. p. 103059.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.redox.2024.103059
UR - https://linkinghub.elsevier.com/retrieve/pii/S2213231724000351
TI - A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization
T2 - Redox Biology
AU - Li, Chunlu
AU - Deng, Chengsi
AU - Wang, Siwei
AU - Wang, Si-wei
AU - Dong, Xiang Da
AU - Bing, Dan
AU - Dai, Bing
AU - Guo, Wendong
AU - GUO, QIQIANG
AU - Guo, Qiqiang
AU - Feng, Yan-Ling
AU - Xu, Hongde
AU - Song, Xiaoyu
AU - Cao, Liu
PY - 2024
DA - 2024/04/01
PB - Elsevier
SP - 103059
VL - 70
PMID - 38316066
SN - 2213-2317
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Li,
author = {Chunlu Li and Chengsi Deng and Siwei Wang and Si-wei Wang and Xiang Da Dong and Dan Bing and Bing Dai and Wendong Guo and QIQIANG GUO and Qiqiang Guo and Yan-Ling Feng and Hongde Xu and Xiaoyu Song and Liu Cao},
title = {A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization},
journal = {Redox Biology},
year = {2024},
volume = {70},
publisher = {Elsevier},
month = {apr},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2213231724000351},
pages = {103059},
doi = {10.1016/j.redox.2024.103059}
}